London, United Kingdom, January 16, 2016 --(PR.com
)-- This masterclass will describe the principles of molecular imaging of the brain and describe the application of molecular imaging techniques to the investigation of neurodegenerative disease and the evaluation of novel pharmaceuticals. A set of interactive presentations will allow the participants to understand the basics and provide the foundation for future development.
For more information or to register visit the event website www.smi-online.co.uk/2016cns-development.asp or contact Matthew Apps on +44 20 7827 6093 or email: email@example.com
Benefits Of Attending:
• Gain a real insight in optimising imaging modailities to visualise disease progression and drug response
• Learn how to obtain the highest quality imaging standards
• Explore practical considerations and overcome major limitations, whilst shedding light on future trends
• Work with peers on how new techniques and concepts can create a major opportunity in the main CNS domains: Depression, Schizophrenia and Alzheimer Disease
There is currently an early bird offer saving £100 off the current price. To take advantage of this book before the 29th January 2016.
To register visit the event website www.smi-online.co.uk/2016otcmedicines.asp or contact Matthew Apps on +44 20 7827 6093 or email: firstname.lastname@example.org
The Application of Molecular and Functional Imaging in Neurodegenerative Disease Masterclass
Phone: Matthew Apps on +44 20 7827 6093
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the worlds most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk